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Abstract
Respiratory syncytial virus (RSV) and human Metapneumovirus (hMPV), viruses belonging to the family Paramyxoviridae, are
the most important causes of lower respiratory tract infection in young children. Infections with RSV and hMPV are clinically
indistinguishable, and both RSV and hMPV infection have been associated with aberrant adaptive immune responses.
Myeloid Dendritic cells (mDCs) play a pivotal role in shaping adaptive immune responses during infection; however, few
studies have examined how interactions of RSV and hMPV with individual mDC subsets (BDCA-1+ and BDCA-3+ mDCs) affect
the outcome of anti-viral responses. To determine whether RSV and hMPV induce virus-specific responses from each subset,
we examined co-stimulatory molecules and cytokines expressed by BDCA-1+ and BDCA-3+ mDCs isolated from peripheral
blood after infection with hMPV and RSV, and examined their ability to stimulate T cell proliferation and differentiation. Our
data show that RSV and hMPV induce virus-specific and subset-specific patterns of co-stimulatory molecule and cytokine
expression. RSV, but not hMPV, impaired the capacity of infected mDCs to stimulate T cell proliferation. Whereas hMPV-
infected BDCA-1+ and BDCA-3+ mDCs induced expansion of Th17 cells, in response to RSV, BDCA-1+ mDCs induced
expansion of Th1 cells and BDCA-3+ mDCs induced expansion of Th2 cells and Tregs. These results demonstrate a virus-
specific and subset-specific effect of RSV and hMPV infection on mDC function, suggesting that these viruses may induce
different adaptive immune responses.
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Introduction
Respiratory Syncytial Virus (RSV) represents the most impor-
tant cause of acute lower respiratory tract infection (LRTI) in
infants, young children, elderly, and immunocompromised indi-
viduals worldwide and is associated with significant short- and
long-term morbidity including bronchiolitis, pneumonia, and
abnormal pulmonary functions. Infection with human Metapneu-
movirus (hMPV) is second only to RSV as a cause of LRTI in
early childhood. Infections with RSV and hMPV are clinically
indistinguishable with overlapping spectra of disease symptoms.
Moreover, both RSV and hMPV can cause wheezing and
exacerbations of asthma in children and adults [1–3] and severe
disease has been linked to the development of asthma and atopy
[4–9]. RSV and hMPV are single-stranded RNA viruses
belonging to the Paramyxoviridae family, and despite similarities in
their genomic organization, two major differences do exist: hMPV
lacks the nonstructural proteins NS1 and NS2 and the gene order
is different [10].
Resolution of infection with these viruses is likely mediated by a
similar array of immune mechanisms involving innate and cellular
immunity, and the lack of long-lasting protection against
reinfection and propensity for severe disease in susceptible
individuals suggests that both RSV and hMPV have the ability
to suppress or subvert host adaptive immune responses. Severe
RSV infection has been associated with skewing the Th1/Th2
balance of the virus-specific response away from antiviral Th1
responses towards Th2 [11–13]. Similar findings in atopy and
asthma suggest that Th2 responses induced during RSV infection
may have an important pathophysiological role in the develop-
ment of wheezing and asthma. Additionally, studies in murine
models of acute RSV infection indicate that Tregs play an
important role in determining the balance between effective
antiviral immunity and controlling harmful immunopathology in
the host response against RSV [14,15]. Recent data also implicates
Th17 lymphocytes as being important contributors to both the
protective immune responses [16,17], as well as the pathology
associated with RSV infection [18]. The cellular response during
hMPV infection in patients is not well described, although findings
in murine models suggest that hMPV also induces aberrant T cell
responses [19]. The mechanisms by which each virus is able to
modulate the host immune response have not been fully
elucidated, however, dendritic cells (DCs), as key regulators of
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immunity, are an ideal target for the virus to exert its immune
altering mechanisms.
DCs are regarded as the most potent professional antigen
presenting cell (APC) type and are an important first line of
defense against invading pathogens. Upon antigen recognition,
DCs produce cytokines and co-stimulatory signals needed to guide
T cell differentiation, ultimately determining the quality and
quantity of the resulting immune response. Different populations
of human DCs are defined based on their lineage and expression
of unique Blood Dendritic Cell Antigens (BDCA). Plasmacytoid
DCs (pDCs) mediate antiviral immunity via the production of
IFN-a and are characterized by expression of BDCA-2 [20].
Myeloid DCs (mDCs), particularly efficient in the uptake,
processing and presentation of antigens, are further subdivided
into functionally distinct subsets identified by differential expres-
sion of either BDCA-1 (BDCA-1+) or BDCA-3 (BDCA-3+) [21–
24]. The DC network in the airway mucosa is comprised mainly of
mDCs, with BDCA-3+ mDCs predominating [25,26], and during
respiratory infections, both tissue-resident and recruited DCs are
activated as part of the host immune response [27]. While the
Figure 1. BDCA-1+ and BDCA-3+ mDCs are susceptible to infection with hMPV. (A) Kinetics of hMPV infection. BDCA-1+ and BDCA-3+ mDCs
were exposed to hMPV at a MOI = 5 for 12, 24, or 40 hours. The percentage of live cells expressing anti-hMPV antibody was quantified using flow
cytometry. Filled grey curve = uninfected DCs, solid line = hMPV-infected DCs,. Data is from one donor and is representative of three donors. (B)
Comparison of hMPV infection rates in BDCA-1+ vs. BDCA-3+ mDCs (mean + SEM of three donors). (C) Comparison of infection rates by RSV vs. hMPV
in each subset (mean + SEM of three donors).
doi:10.1371/journal.pone.0099227.g001
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relationship between mDCs found in the lung and peripheral
blood is not clear, parallel phenotypic analysis and transcriptome
mapping provides evidence that lung and other non-lymphoid
tissue mDC subsets are phenotypically and functionally related to
mDC subsets found in the circulation [28]. The strategic
localization of DCs at the site of pathogen entry makes them
particularly susceptible to initial viral invasion, thus studying the
interactions of DCs with viruses and how this may influence the
resulting immune response is critical for understanding disease
pathogenesis and immunity to viral infections.
Much of what we know about the effects of RSV and hMPV
infection on DC function comes from studies using murine DCs or
mDCs derived in vitro from human monocytes (Mo-DCs). Studies
with Mo-DCs have shown a differential response to infection with
RSV and hMPV, suggesting that RSV and hMPV may use
distinct mechanisms to interfere with host immune responses.
However, although Mo-DCs have many characteristics similar to
primary myeloid blood DCs, studies have not shown direct
functional correlations between in vitro derived Mo-DCs and
individual mDC subsets isolated from lymph nodes or blood
[22,29,30]. Furthermore, Mo-DCs are unable to give rise to cells
that are phenotypically or functionally equivalent to BDCA-3+
mDCs [22]. Thus, studies using Mo-DCs may not adequately
recapitulate the function of diverse human mDC subsets during
infection.
We have recently described a subset-specific effect of RSV on
the functional response of BDCA-1+ and BDCA-3+ mDCs [31].
Findings of differential responses as compared to stimulation with
the TLR3 agonist Poly I:C also suggests a virus-specific effect of
RSV infection on BDCA-1+ and BDCA-3+ mDC function,
although comparisons with other viruses was not made [31].
Specifically, the effect of hMPV infection on the functional
response of primary mDC subsets has not been examined.
Therefore, to identify the specific responses of BDCA-1+ and
BDCA-3+ mDCs to hMPV infection and to determine whether
RSV and hMPV induce virus-specific responses from each subset,
we examined co-stimulatory marker expression and cytokine
production by donor-matched BDCA-1+ and BDCA-3+ mDCs
after infection with hMPV and RSV. The functional response
after infection was further evaluated by examining their ability to
stimulate CD4+ T cell proliferation and differentiation in a mixed
lymphocyte reaction.
Materials and Methods
Ethics Statement
This study was approved by UTMB’s Institutional Review
Board.
Isolation of mDC Subsets
Buffy coats prepared by the University of Texas Medical
Branch (UTMB) blood blank from healthy adult donors who
fulfilled criteria for blood donations were obtained. The donor’s
identity, race, and age remained anonymous to investigators. The
isolation of mDC subsets from buffy coats has been previously
described [31]. Briefly, peripheral blood mononuclear cells
(PBMCs) were separated from buffy coats by Ficoll-hypaque
density centrifugation and enriched for mDCs using an mDC cell
isolation kit (Miletnyi Biotec, Auburn, CA) to deplete magnetically
labeled non-mDCs. In preparation for FACS sorting, the DC
enriched fraction was stained with the following fluorochrome-
conjugated monoclonal antibodies (mAbs[clone]): PE-BDCA-
3[1A4], APC-BDCA-1[AD5-8E7], FITC-BDCA-2[AC144], and
FITC-lineage marker cocktail containing CD3[SK7],
CD14[MWP9], CD16[3G8], CD19[SJ25C1], CD20[L27],
CD56[NCAM16.2] purchased from eBiosciences (San Diego,
CA), Miltenyi Biotec, and BD Biosciences (San Jose, CA)
respectively. Cells were stained in the presence of FcR-blocking
reagent (Miltenyi Biotec) to minimize non-specific binding. Gating
strategy for the identification and sorting of BDCA-1+ and BDCA-
3+ mDCs has been previously described [31]. BDCA-3+ mDCs
were sorted as FITC2, APC2, PEhi and BDCA-1+ mDCs were
sorted as FITC2, APC+, PEdim. Routine post-sort analysis showed
purity $95%. Cell sorting was performed on a FACSAria (BD
Biosciences) capable of 9-color analysis running FACS Diva
software.
Virus Preparation and Infection
Preparation of sucrose-purified RSV (Long strain) and hMPV
(CAN97-83) have been previously described [32]. For infection,
16104 cells of donor-matched BDCA-1+ or BDCA-3+ mDCs were
resuspended in 200 ml of cRPMI (RPMI 1640 medium +2 mmol/
liter L-glutamine +2% FBS+50 mM 2-ME+100 UI/mL penicillin-
streptomycin) and incubated for 40 hours at 37uC with RSV or
hMPV at a multiplicity of infection (MOI) of 5 [32,33]. For
hMPV-inoculated cells, the medium also contained 1 mg/ml of
trypsin during the infection process. Uninfected cells served as
negative controls. When indicated, mDCs were also incubated
with ultraviolet (UV)-inactivated RSV and hMPV (non-replicating
virus) as additional controls.
FACS Analysis of DCs
To detect intracellular expression of RSV and hMPV antigens,
BDCA-1+ and BDCA-3+ mDCs were fixed with Cytofix/
Cytoperm (Pharmingen), permeabilized with Perm/Wash buffer
(Pharmingen), and stained with a monoclonal FITC-conjugated
anti-RSV antibody (Biosource, Camarillo, CA) or with guinea pig
anti-hMPV Ab, followed by a polyclonal FITC-goat anti-guinea
pig Ab (Zymed Laboratories, Carlsbad, CA) as previously
described [32]. Viability of infected cells was determined by first
staining with Fixable viability dye eFlour780 (eBioscience). For co-
stimulatory molecule analysis, mDCs were stained with FITC-PD-
L1[M1H1], v450-CD86[2331(FUN-1)], and PE-Cy7-
CD80[L307.4] (BD Biosciences). Flow cytometric data acquisition
for all studies was performed on a BD LSRII Fortessa capable of
18-color analysis running FACS Diva software (BD Biosciences).
FloJo V7.6.3 software was used to analyze all flow cytometry data.
Measurement of Cytokine and IFN-a Production
After 40 hours, cell free supernatants were collected and tested
for cytokines IL-1b, IL-1ra, IL-6, IL-7, IL-8/CXCL8, IL-10, IL-
12(p70), IP-10/CXCL10, G-CSF, MCP-1/CCL2, MIP-1a/
CCL3, MIP-1b/CCL4, RANTES/CCL5, and TNF-a, using the
Luminex-based Bio-Plex system (Bio-Rad Laboratories, Hercules,
CA). The lower limit of detection for all cytokines measured in this
assay is 3 pg/ml. When comparing cytokine production between
subsets, the fold change in concentration (infected/uninfected) was
used to normalize results across cell types. To measure the
production of IFN-a, the cell-free supernatant was collected at 24
hours. Human IFN-a concentration was determined by commer-
cial ELISA assays according to the manufacturer’s instructions
(PBL, Piscataway, NJ).
CD4+ T Cell Proliferation Assay
Allogeneic CD4+ T cells were isolated from PBMCs by negative
immunomagnetic selection using a CD4+ T cell isolation kit
(Miletnyi Biotec, Auburn, CA). Routine post-sort purity was .
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96% as determined by flow cytometry. To track proliferation, T
cells were labeled with 10 mM CFSE (Invitrogen, Grand Island,
NY) according to the manufacturer’s instructions. Donor-matched
BDCA-1+ and BDCA-3+ mDCs were incubated at 37uC with
RSV, hMPV, UV-RSV, or UV-hMPV. After 24 hours, cells were
washed and co-cultured with the CFSE-labeled allogeneic T cells
at a ratio of 1:5 in RPMI containing 5% FCS for 7 days at 37uC. T
cells alone and T cells incubated with soluble CD3 and CD28
were included as controls. Prior to flow cytometry, cells were
stained with a fixable viability dye eFlour 780 (eBioscience),
PerCP-Cy 5.5-CD3[SK7], and PE-Cy 7-CD4[RPT-A] (BD
Biosciences). Proliferation of CD3+ CD4+ T cells was measured
by the loss of CFSE dye that occurs with cell division.
CD4+ T Cell Differentiation Assay
For T cell differentiation studies, donor-matched BDCA-1+ and
BDCA-3+ mDCs were incubated for 24 hours at 37uC with RSV,
UV-RSV, hMPV, or UV-hMPV. After 24 hours, cells were
Figure 2. Virus induced expression of co-stimulatory molecules by BDCA-1+ and BDCA-3+mDCs. (A) Co-stimulatory molecule expression
on mDCs exposed to hMPV and RSV were analyzed by flow cytometry. Filled grey curve = uninfected DCs, solid line =hMPV-infected DCs, dotted line
= RSV infected DCs. Data is from one donor and is representative of five donors. (B) Mean fluorescence intensity (MFI) of CD86, CD80, and PD-L1
expression by uninfected, RSV- and hMPV-infected mDCs from five donors (mean + SEM). Black bars = uninfected, white bars = hMPV, grey bars =
RSV,. *p#0.05 as calculated by 1-way repeated measures ANOVA with Tukey post-hoc analysis.
doi:10.1371/journal.pone.0099227.g002
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washed and co-cultured with allogeneic CD4+ T cells at a ratio of
1:5 in RPMI containing 5% FCS for 8 days at 37uC. On day 8,
cells were harvested and stained with fixable viability dye eFlour
780 (eBioscience) to discriminate between live and dead cells, PE-
Cy 7-CD4[RPT-A], and BV 605-CD25[2A3] (BD Biosciences)
according to the manufacturer’s instructions. The cells were fixed
and permeabilized according to the manufacturer’s instructions
using the Foxp3 Transcription Factor Staining Buffer Set
(eBiosciences) and immunostained with Fastimmune FITC-IFN-
c[25723.11]/PE-IL-4[3010.211] (BD Biosciences), APC-
Foxp3[PCH101] (eBioscience), PerCP-Cy5.5-IL-17A [eBio64-
DEC17] (eBioscience).
Statistical Analysis
Statistical Analysis was performed with InStat 5.02 biostatistics
package (GraphPad Software, San Diego, CA) using one-way
repeated measures analysis of variance (ANOVA) with Tukey
post-hoc tests or paired t-tests to ascertain differences in the
responses with a given subtype, and two-way ANOVA with
Bonferroni post hoc tests were used to ascertain differences
between cell types. Significance was defined as p#0.05. Prior to
analysis, data sets were log transformed to normalize non-normally
distributed data. Data are reported as non-normalized values.
Results
BDCA-1+ and BDCA-3+ mDCs are Permissive to Infection
with hMPV
Work from our lab has shown that Mo-DCs are susceptible to
infection with RSV and hMPV [32], and we have recently shown
that BDCA-1+ and BDCA-3+ mDCs are permissive to infection
with RSV, with maximal infection rates occurring at a MOI = 5
[31]. To determine the susceptibility of primary mDCs to infection
with hMPV, the intracellular expression of viral proteins by live
BDCA-1+ and BDCA-3+ mDCs infected with hMPV at a
MOI = 5 for 12, 24, and 40 hours was examined using flow
cytometry. An MOI of 5 was chosen to maintain consistency for
comparisons between RSV and hMPV. Expression of viral protein
by BDCA-1+ and BDCA-3+ mDCs infected with hMPV was
detected at all time points, (Fig. 1A). As in Mo-DCs [32], the
number of hMPV positive cells did not increase with longer
incubation times, suggesting that while primary mDCs are
Figure 3. Cytokine production by hMPV-infected mDCs. (A) BDCA-1+ and (B) BDCA-3+ mDCs were isolated and incubated with hMPV or
media for 40 hours. Cytokine and chemokine levels were measured in cell-free supernatant by multiplex assay. Data represent cytokine production in
pg/ml. Box and whisker plots show the median (central bar), interquartiles (boxes), and range (whiskers) of the data from 6 donors. Linear data is
reported on a logarithmic scale. Black bars = uninfected cells, white bars = hMPV-infected cells. Dotted line = threshold level of detection, 3 pg/ml.
*p#0.05 between infected and uninfected cells as calculated by paired t-test.
doi:10.1371/journal.pone.0099227.g003
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susceptible to hMPV infection, viral replication is restricted. Cell
viability did decrease between 24 and 40 hours; however, there
was no significant difference in cell viability between infected and
uninfected cells at any given time point (data not shown). When
comparing the rates of hMPV infection between BDCA-1+ and
BDCA-3+ mDCs, no significant difference was noted in the
percentages of BDCA-1+ mDCs (22–25%) and BDCA-3+ mDCs
(20–22%) expressing viral proteins (Fig. 1B). Additionally, there
was no statistically significant difference between the percentages
of RSV- and hMPV-infected cells (Fig. 1C). Although cell viability
in RSV-infected mDCs was noted to be decreased as compared to
hMPV-infected mDCs, these differences were not statistically
significant (data not shown).
hMPV and RSV Induce Distinct Patterns of Co-stimulatory
Molecule Expression by BDCA-1+ and BDCA-3+ mDCs
The co-stimulatory molecules expressed by DCs are critical in
determining the fate of T cell activation and differentiation. CD86
and CD80 expressed on mDCs can deliver either stimulatory
(CD28) or inhibitory (CTLA-4) signals for T cell activation [34].
Additionally, the programmed death-1 (PD-1) receptor and its
ligands PD-L1 and PD-L2 deliver inhibitory signals that regulate
the balance between tolerance vs. T cell activation and immune-
mediated tissue damage. To determine the effect of hMPV
infection on co-stimulatory molecule expression by primary mDCs
and to assess whether RSV and hMPV differentially regulate co-
stimulatory molecule expression, the expression of CD86, CD80,
and PD-L1 on hMPV- and RSV-infected BDCA-1+ and BDCA-
3+ mDCs was examined using flow cytometry (Fig. 2A). BDCA-1+
and BDCA-3+ mDCs infected with hMPV did not demonstrate
significantly increased expression of CD86, CD80, and PD-L1 as
compared to uninfected cells (Fig. 2B). Overall, RSV was a more
potent inducer of CD80, CD86, and PD-L1 expression than
hMPV, with significant differences in PD-L1 expression by RSV-
infected BDCA-1+ mDCs, and CD86 and PD-L1 expression by
RSV-infected BDCA-3+ mDCs (Fig. 2B).
hMPV and RSV Induce Distinct Patterns of Cytokine and
Chemokine Production by BDCA-1+ and BDCA-3+ mDCs
DC-derived cytokines and chemokines are at the center of the
complex network of cells that regulate the outcome of innate and
cellular immune responses. In both murine DCs and Mo-DCs,
cytokine production is differentially induced by RSV and hMPV,
with RSV being a more potent inducer of IL-10, TNF-a, IL-1b
and IL-12 and hMPV being a more potent producer of IFN-a
[32]. We have shown that RSV-infection induces differential
cytokine production by BDCA-1+ and BDCA-3+ mDCs [31]. To
define the profile of cytokines produced by primary mDC subsets
in response to hMPV infection, cytokine production by hMPV-
infected BDCA-1+ and BDCA-3+ mDCs was examined using a
Luminex-based assay. Compared to uninfected cells of the same
type, hMPV-infected BDCA-1+ mDCs demonstrated significant
increases in the production of IL-1b, IL-1ra, IL-6, IL-8, IL-12, IP-
10, MCP-1, MIP-1a, MIP-1b, and RANTES (Fig. 3A). In hMPV-
infected BDCA-3+ mDCs, only IP-10, MCP-1 and RANTES
levels were found to be significantly increased as compared to
uninfected cells of the same type (Fig. 3B). Neither BDCA-1+ or
BDCA-3+ mDCs infected with hMPV were found to produce
significant amounts of IL-10, G-CSF, or TNF-a. In order to
determine whether hMPV-infection induced distinct patterns of
cytokine expression from BDCA-1+ and BDCA-3+ mDCs, the fold
change in cytokine production (infected/uninfected) by each cell
type was compared (Fig. 4). A two-factor analysis of variance
showed a significant effect of cell type on cytokine production in
response to hMPV, [F(1,104) = 125.8, p,.00001], as well as a
significant effect of the cytokine being produced
[F(12,104) = 37.44, p,.00001]. Overall, hMPV-infection induced
greater amounts of cytokine production from BDCA-1+ than from
BDCA-3+ mDCs. However, there was a significant interaction
between cell type and cytokine, [F(12,104) = 7.77, p,.00001]
suggesting that the effect of cell type was not the same on all
cytokines, and compared to BDCA-3+ mDCs, hMPV-infected
BDCA-1+ mDC were found to produce significantly greater
amounts of IL-1b, IL-6, IL-8, MIP-1a, and MIP-1b. IL-1ra, IL-
10, IL-12, G-CSF, IP-10, MCP-1, RANTES, and TNF-a
production were not significantly different between the two cell
types.
Figure 4. Comparison of selected cytokines produced by hMPV-infected BDCA-1+ vs. BDCA-3+ mDCs. DC subsets were isolated and
incubated with hMPV or media for 40 hours. Cytokine and chemokine levels were measured in cell-free supernatant by multiplex assay. Data
represents the mean + SEM of the fold change in cytokine production by infected cells as compared to uninfected cells of the same type from 6
donors. Linear data is reported on a logarithmic scale. The dotted line represents a 2 fold induction from baseline. Black bars = uninfected cells, white
bars = hMPV-infected cells. *p#0.05 between BDCA-1+ and BDCA-3+ mDCs as calculated by 2-way ANOVA with Bonferroni post-hoc test.
doi:10.1371/journal.pone.0099227.g004
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Figure 5. Comparison of cytokines produced by mDC subsets in response to RSV vs. hMPV. (A) BDCA-1+ and (B) BDCA-3+ mDCs were
isolated and incubated with RSV, hMPV or media alone for 40 hours. Cytokine and chemokine levels were measured in cell-free supernatant by
multiplex assay. Data represents the mean + SEM of the fold change (infected/uninfected) in cytokine production by RSV vs. hMPV-infected mDCs
from 6 donors. Linear data is reported on a logarithmic scale. The dotted line represents a 2 fold induction. Grey bars = RSV-infected cells, white
bars = hMPV-infected cells. *p#0.05 between RSV and hMPV-infected mDCs as calculated by paired t-test.
doi:10.1371/journal.pone.0099227.g005
Figure 6. IFN-a production by RSV and hMPV-infected BDCA-1+ and BDCA-3+ mDCs. IFN-a production was assessed by ELISA in the
supernatant of (A) BDCA-1+ and (B) BDCA-3+ mDCs incubated with RSV, hMPV, UV-RSV, UV-hMPV, or media for 40 hours (mean + SEM from 3 donors).
*p#0.05 between treated mDCs as calculated by repeated measures one-way ANOVA with Tukey post-hoc analysis. (C) Comparison of IFN-a
production by hMPV-infected BDCA-1+ vs. BDCA-3+ mDCs (mean + SEM from 3 donors). * = p#0.05 between BDCA-1+ and BDCA-3+ mDCs as
calculated by paired t-test.
doi:10.1371/journal.pone.0099227.g006
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Various reports in Mo-DCs and murine lung DCs have
demonstrated impaired cytokine production by hMPV-infected
DCs as compared to those infected with RSV [32,35,36]. To
determine whether RSV and hMPV induce virus-specific patterns
of cytokine expression, the fold change in cytokine production
(infected/uninfected) by donor-matched RSV- and hMPV-infect-
ed cells was compared for each mDC subtype (Fig. 5). In general,
RSV was found to induce more robust cytokine production from
both BDCA-1+ and BDCA-3+ mDCs when compared to hMPV.
With the exception of IP-10, produced in greater amounts by
hMPV-infected BDCA-1+ mDCs, and MCP-1, which was not
significantly different between RSV and hMPV infected BDCA-1+
mDCs, RSV-infected BDCA-1+ mDCs produced greater amounts
of all cytokines tested (Fig. 5A). RSV-infected BDCA-3+ mDCs
produced greater amounts of IL-1ra, IL-6, IL-8, IL-10, MIP-1a,
MIP-1b, and RANTES. IL-1b, IL-12, G-CSF, IP-10, MCP-1, and
TNF-a production by RSV and hMPV-infected BDCA-3+ mDCs
was not significantly different (Fig. 5B).
Type 1 interferons (IFNs) are a group of cytokines that activate
an array of cellular genes critical in restricting viral replication and
modulating adaptive immunity, and the production of IFNs is an
important feature of the host response to viral infections [37,38].
In Mo-DCs, hMPV, but not RSV, is a potent inducer of IFN-a
production [32]. To assess the ability of primary mDCs to produce
IFN-a in response to hMPV infection, the production of IFN-a by
RSV- and hMPV-infected BDCA-1+ and BDCA-3+ mDCs was
measured using ELISA. In both BDCA-1+ and BDCA-3+ mDCs,
IFN-a was produced by hMPV-infected cells, but not RSV-
infected cells (Fig. 6A). As expected, IFN-a was not produced by
mDCs exposed to UV-hMPV indicating that IFN-a production by
mDCs is dependent on viral replication. When comparing IFN-a
production between subsets, hMPV-infected BDCA-1+ mDCs
produced greater amounts of IFN-a than did hMPV-infected
BDCA-3+ mDCs (Fig. 6B).
Differential Effect of hMPV and RSV Infection on the
Ability of mDCs to Stimulate CD4+ T Cell Proliferation
BDCA-1+ and BDCA-3+ mDCs are powerful and equivalent
stimulators of allogeneic CD4+ T cells [24]. We have previously
demonstrated that infection with RSV impairs the capacity of
primary mDCs to stimulate T-cell proliferation [31]. To assess the
effect of hMPV infection on the ability of BDCA-1+ and BDCA-3+
Figure 7. RSV, but not hMPV, impairs the ability of BDCA-1+ and BDCA-3+ mDCs to stimulate CD4+ T cell proliferation. BDCA-1+ and
BDCA-3+ mDC were incubated with RSV, hMPV, UV-hMPV, or media for 24 hours and co-cultured with CFSE-labeled allogeneic CD4+ T cells. On day 7,
T cell proliferation was measured by examining CFSE expression on live CD4+ T cells. (A) Data represent the percentage of proliferating cells from one
donor and is representative of data from 3 donors. (B) Bar graphs represent the percent of proliferating CD4+ T cells (mean + SEM from 3 donors).
* = p#0.05 between co-cultures with treated mDCs as calculated by one-way repeated-measures ANOVA with Tukey post-hoc analysis.
doi:10.1371/journal.pone.0099227.g007
Human DC Subsets and T Cell Responses to RSV and hMPV
PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e99227
mDCs to stimulate T cell proliferation, allogeneic CD4+ T cells
labeled with CFSE were co-cultured with BDCA-1+ and BDCA-3+
mDCs exposed to hMPV, RSV, UV-hMPV and UV-RSV for 7
days. BDCA-1+ and BDCA-3+ mDCs infected with hMPV
demonstrated a reduced capacity to stimulate T cell proliferation
as compared to uninfected mDCs or mDCs exposed to UV-hMPV
(Fig. 7A). However, in contrast to RSV-infected mDCs, there was
no statistically significant difference in the percent of proliferating
T cells between co-cultures with hMPV-infected and uninfected
mDCs (Fig. 7B).
Differential Effect of hMPV and RSV Infection on Skewing
of Th Polarization by Infected BDCA-1+ and BDCA-3+
mDCs
The balance of the T helper subsets induced during infection
plays a crucial role in determining the short- and long-term
sequela of disease. To assess the effect of RSV and hMPV
infection on the capacity of BDCA-1+ and BDCA-3+ mDCs to
skew T cell polarization, allogeneic CD4+ T cells were co-cultured
with mDCs exposed to RSV, hMPV, UV-RSV, or UV-hMPV.
On day 8 post-infection, cells were collected and stained for
extracellular expression of CD4 and CD25, and intracellular
expression of IFN-c, IL-4, IL-17A, and Foxp3. Cells were also
stained with a fixable viability dye to discriminate between live and
dead cells. The expression of IFN-c, IL-4, IL-17A, and CD25 and
Foxp3 was examined on live CD4+ T cells to identify Th1 (IFN-
c+), Th2 (IL-4+), Th17 (IL-17A+), and Treg (CD25+, Foxp3+)
populations respectively (Fig. S1A–B). As expected, there were
decreased numbers of live T cells in the co-cultures with RSV-
infected mDCs as compared to co-cultures with hMPV-infected
mDCs. This is likely due to the suppressive effect of RSV-infection
on T cell proliferation, as there was no statistically significant
difference in the percent of dead CD4+ T cells between co-cultures
(data not shown). Compared to co-cultures with uninfected
Figure 8. Skewing of CD4+ T cell polarization by virus-infected mDCs. Allogeneic CD4+ T cells were co-cultured with (A) BDCA-1+ and (B)
BDCA-3+ mDCs incubated with RSV, hMPV, UV-RSV, UV-hMPV, or media. The percentage of live CD4+ T cells positive for expression of IFN-c (Th1), IL-4
(Th2), IL-17A (Th17), and CD25+, Foxp3 (Tregs) was quantified using flow cytometry (mean + SEM from three donors). *p#0.05 between the
percentage of positive T cells from co-cultures with treated mDCs vs. co-cultures with uninfected DCs as calculated by one-way repeated-measures
ANOVA with Tukey post-hoc analysis.
doi:10.1371/journal.pone.0099227.g008
Human DC Subsets and T Cell Responses to RSV and hMPV
PLOS ONE | www.plosone.org 9 June 2014 | Volume 9 | Issue 6 | e99227
BDCA-1+ mDCs, there was an increased percentage of IFN-c+ T
cells in co-cultures with RSV-infected BDCA-1+ mDCs and an
increased percentage of IL-17A+ T cells in co-cultures with
hMPV-infected BDCA-1+ mDCs (Fig. 8A). There was no
difference in the percent of IL-4+ or CD25+, Foxp3+ T cells
between co-cultures with infected and uninfected BDCA-1+
mDCs. Compared to co-cultures with uninfected BDCA-3+
mDCs, co-cultures with hMPV-infected BDCA-3+ mDCs had
an increased percentage of IL-17A+ T cells, and co-cultures with
RSV-infected BDCA-3+ mDCs were found to have increased
percentages of IL-4+ and CD25+, Foxp3+ T cells (Fig. 8B). For
both BDCA-1+ and BDCA-3+ mDCs, the percentages of Th
subsets in co-cultures with mDCs exposed to UV-inactivated RSV
and hMPV were not significantly different than those found in co-
cultures with uninfected mDCs. When comparing the Th types
induced by BDCA-1+ mDCs to those induced by BDCA-3+
mDCs, RSV-infected BDCA-1+ mDCs were found to induce a
greater percentage of IFN-c+ T cells, whereas RSV-infected
BDCA-3+ mDCs induced a greater percentage of IL-4+ and
CD25+, Foxp3+ T cells (Fig. 9). There was no difference in the
percentage of IFN-c+, IL-4+, IL-17A+, or CD25+, Foxp3+ T cells
induced by hMPV-infected BDCA-1+ and BDCA-3+ mDCs.
Discussion
Both RSV and hMPV infection have been associated with
aberrant adaptive T cell responses [11,12,14,17,19], and DCs play
a central role in the induction and regulation of virus-specific
adaptive immune responses in the respiratory tract. Although Mo-
DCs infected with RSV or hMPV have not been found to skew T
Figure 9. Comparison of Skewing of CD4+ T cell polarization by BDCA-1+ vs. BDCA-3+ mDCs. The percentage of each Th subset in T cell
co-cultures with infected and uninfected BDCA-1+ vs. BDCA-3+ mDCs. *p#0.05 between co-cultures with BDCA-1+ and BDCA-3+ mDCs as calculated
by paired t-test.
doi:10.1371/journal.pone.0099227.g009
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cells away from the Th1 compartment [39], phenotypic and
functional differences between BDCA-1+ and BDCA-3+ mDCs
suggest that each subset plays a distinct role in coordination of
immune responses during infection, and studies in both mice [40–
42] and humans [43–45] demonstrate a specific role for BDCA-3+
mDCs in the development of Th2 and Treg responses. In this
study, we demonstrate a virus-specific and subset-specific effect of
RSV and hMPV infection on the regulation of CD4+ T cell
responses by primary mDCs. We show that similar to Mo-DCs
[32,35,46,47], BDCA-1+ and BDCA-3+ mDCs are susceptible to
infection with RSV and hMPV and that infection with RSV, but
not hMPV, impaired the capacity of primary mDCs to stimulate T
cell proliferation. We also provide novel evidence demonstrating
that in co-cultures with allogeneic CD4+ T cells, RSV-infected
BDCA-1+ preferentially induced expansion of Th1 cells, whereas
RSV-infected BDCA-3+ induced expansion of the Th2 and Treg
compartments. Moreover, polarization of T cells away from Th1
responses by RSV-infected BDCA-3+ mDCs was also virus-
specific, as both BDCA-1+ and BDCA-3+ mDCs infected with
hMPV induced Th17 cell expansion.
Both the type and the strength of the co-stimulatory molecule
signals produced by activated DCs determine the outcome of
immune responses [48], and the differential expression of PD-L1
by RSV-infected BDCA-1+ and BDCA-3+ mDCs suggests a
possible mechanism by which RSV infection could impair the
ability of mDCs to stimulate T cell proliferation. Similar to
findings in Mo-DCs [32,35], even though hMPV was not found to
be a strong inducer of co-stimulatory molecule expression, hMPV-
infected mDCs did not inhibit T cell proliferation. The reason for
this is unclear. Comparable infection rates by RSV and hMPV
suggest that differences in infectivity did not lead to decreased
mDC activation. However, it is not known what threshold level of
co-stimulatory molecule expression is needed for T cell activation.
Moreover, paracrine signaling by infected DCs has been shown to
activate uninfected DCs [49], and the more robust production of
cytokine signals provided by RSV-infected mDCs may have
resulted in a greater number of activated cells.
RSV and hMPV infection have been shown to induce
differential patterns of cytokine production in both in vitro and
in vivo models of infection [19,36,50–52]. In line with these
observations, RSV and hMPV induced virus-specific and subset-
specific patterns of cytokine production from primary mDCs.
Notably, IL-10 was produced only by RSV-infected mDCs of both
subtypes. DC-derived IL-10 is shown to act in an autocrine fashion
to inhibit pro-inflammatory cytokine production and impair the
capacity of DCs to foster Th1 responses [53]. Moreover, only
hMPV was a potent inducer of IFN-a production by BDCA-1+
and BDCA-3+ mDCs. Type 1 IFNs, such as IFN-a, potentiates
antiviral activity through direct or indirect regulation of the
activity of a number of proinflammatory cytokines and chemo-
kines [37,38,54], promotes T cell proliferation, and inactivates the
suppressive function of human Tregs, thereby releasing CD4+ T
cells from Treg mediated suppression [55]. Additionally, we have
previously shown that RSV induces subset-specific patterns of
cytokine production [31], with differential production of IL-12 and
TNF-a by RSV-infected BDCA-1+ mDCs. In contrast, although
hMPV-infected BDCA-1+ mDCs produced greater amounts of
cytokines than did BDCA-3+ mDCs, IL-12 and TNF-a production
was not significantly different between the two subtypes. Pro-
inflammatory cytokines such as IL-12, IFN-c, and TNF-a are
recognized as Th1 polarizing signals [56,57]. Furthermore, IL-12
has been shown to enhance activation and proliferation of
conventional T cells [58] and reduce the frequency and
proliferation of Tregs [59]. In the periphery, inducible Tregs are
derived from conventional T cells in the context of signals such as
IL-2, IL-10, TGF-b, CD80/CD86, and PD-L1 [60–62]. Differ-
ential expression of CD86 by RSV-infected BDCA-3+ mDCs with
the concomitant induction of IL-12 and other pro-inflammatory
cytokines by RSV-infected BDCA-1+ mDCs, may explain the
subset-specific effect of BDCA-3+ mDCs on Treg expansion
during RSV infection. The cytokine signature associated with Th2
skewing is not as clearly defined; however, along with IL-4 and IL-
10, low levels of IL-12 have been identified as Th2 polarizing
signals [56,57,63]. Although RSV-infected BDCA-3+ mDCs were
not found to produce IL-4, Th2 polarizing signals may have come
from the activation and expansion of Th2 memory T cells in T cell
co-cultures [64–66]. These cells could represent either direct
activation of rare RSV-specific memory T cells or bystander
activation of cross-reacting memory T cells. As Type 1 IFNs drive
Th1 development while suppressing Th2 development [67,68],
differential expression of IFN-a and the absence of CD86, PD-L1
or IL-10 expression by hMPV-infected BDCA-3+ may explain the
virus-specific effect of RSV and hMPV on T cell polarization by
BDCA-3+ mDCs. Th17 cells develop under the influence of IL-1b,
IL-6 and TGF-b, but have been shown to readily convert to a Th1
phenotype under inflammatory conditions [69] and recent
evidence suggests that Th1 and Th17 cells may collaborate in
the immune response against certain pathogens where Th17 cells
precede and potentiate a Th1 response [70]. Th17 expansion in T
cells co-cultured with hMPV-infected BDCA-1+ and BDCA-3+
mDCs may have resulted from the lack of adequate pro-
inflammatory cytokine signals from hMPV-infected mDCs in vitro.
Thus, although RSV-infected mDCs generally produced greater
amounts of cytokines than hMPV-infected mDCs, lower levels of
pro-inflammatory cytokines have not been found to correlate with
decreased disease severity in patients with acute hMPV infection
[50], suggesting that not only do RSV and hMPV utilize distinct
pathways to modulate anti-viral immune responses, but that mDC
subset-specific responses may be an important factor in determin-
ing the outcome of infection and the severity of clinical
manifestations in RSV infection.
The mechanisms driving the differential responses induced by
RSV and hMPV are unclear. Differences in their genomic
structure, as well as differences in the way each virus interacts with
DCs could contribute to the virus-specific responses. The NS1 and
NS2 proteins of RSV inhibit production of IFN-a and drive
production of pro-inflammatory cytokines through activation of
the transcription factor NF-kB [11,71,72], and work from our lab
has shown that the small hydrophobic glycoprotein (SH) of hMPV
inhibits NF-kB dependent gene transcription [73]. Alternatively,
activation of the host defense response is dependent on the
recognition of conserved structural moieties by pattern recognition
receptors (PRR), such as Toll-like receptors (TLRs), present on
immune cells. TLRs convert pathogen recognition to active
cellular responses through a complex network of intracellular
molecules leading to the activation of transcription factors
collaborating with each other to produce a large number of
cytokines and co-stimulatory molecules, and the combination of
signals produced in response to infection is dependent on the
TLRs activated. Both RSV and hMPV have been shown to
activate TLR4 in primary immune cells [74–77]; however, RSV
has also been shown to mediate host immune responses through
TLR3 dependent-signaling pathways [75,78–80]. Moreover,
BDCA-1+ and BDCA-3+ mDCs have been shown to express
discreet TLR profiles [24,81,82] and differences in the way RSV
interacts with each mDC subset may also underlie the subset-
specific effect of RSV on mDC function. Further study to elucidate
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the mechanisms by which these viruses interact with BDCA-1+
and BDCA-3+ mDCs is needed.
To our knowledge, this is the first study to describe the
functional response of primary mDCs to infection with hMPV,
and also to compare their response to the two viruses. We
recognize that the use of mixed lymphocyte reaction assays may
not address antigen-specific responses that occur during natural
infection. However, as it is not known whether RSV infection
impairs the antigen presenting capacity of mDCs, the use of
allogeneic T cells allowed us to focus on the functional activity of
RSV-infected mDCs, independent of the quality or quantity of
antigen presentation. Additionally, the use of total CD4+ T cells in
co-culture experiments does not allow us to differentiate between
Th subsets that arose from differentiation of naı¨ve T cells versus
the conversion or expansion of differentiated T cells as part of a
recall response. However, It is not known what role recall
responses play during acute infection as although more that 95%
of adults have been exposed to RSV during childhood, there is a
low frequency of RSV-specific memory T cells in the peripheral
blood and lungs of healthy adults [83]. Moreover, examination of
the frequency of memory and naı¨ve T cell populations in CD4+ T
cell isolates revealed that the majority of the CD4+ T cells in the
peripheral blood samples used were naı¨ve CD45ra+ T cells (34%
CD45ra+ vs. 17% CD45ro+, data not shown). We recognize that
using a reductionist in vitro model does not represent the
interactions between the complex network of mDC subsets in
the lungs and blood during natural infection and a suitable human
model to further study these questions is needed. Furthermore,
although RSV primarily affects young children, mDC subsets were
isolated from the peripheral blood of healthy adults due to the
feasibility of obtaining sufficient volumes of blood from pediatric
populations. It is not well known whether age dependent
differences in mDC subset function exist [84].
Despite these limitations, the results of this study provides novel
information on the virus-specific and subset-specific role mDC
subsets play in the immune response to Paramyxovirus infection.
These findings suggest that despite the similarities in their clinical
and immunopathologic features, RSV and hMPV utilize different
pathways to modulate the host immune responses during infection,
and that the quality and quantity of individual mDC subsets
during RSV infection plays a crucial role in determining the short-
and long-term sequela of disease. It is not known what type of
mDCs are present in the lungs during natural infection, or how
host genetic and environmental factors affect the downstream
function of BDCA-1+ and BDCA-3+ mDCs interacting with virus.
Defining the mechanisms by which RSV and hMPV are able to
modulate mDC function will provide important new insights into
the immunopathogenesis of paramyxovirus infections and the role
mDC subsets play in the host immune response against pathogens
as a whole.
Supporting Information
Figure S1 Identification of Th subsets in T cell co-
cultures with virus-infected mDCs. Allogeneic CD4+ T cells
were co-cultured with (A) BDCA-1+ and (B) BDCA-3+ mDCs
incubated with RSV, hMPV, UV-RSV, UV-hMPV, or media.
The percentage of live CD4+ T cells positive for expression of IFN-
c (Th1), IL-4 (Th2), IL-17A (Th17), and CD25+, Foxp3 (Tregs)
was quantified using flow cytometry. Data is from one donor and
is representative of three donors.
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